- Home
- DTI vs BDTX Comparison
DTI vs BDTX Comparison
Compare DTI & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DTI | BDTX |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.5M | 116.8M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DTI | BDTX |
|---|---|---|
| Price | $3.60 | $2.13 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.20 |
| AVG Volume (30 Days) | 198.1K | ★ 581.5K |
| Earning Date | 03-05-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 130.71 |
| EPS | N/A | ★ 0.39 |
| Revenue | ★ $154,446,000.00 | N/A |
| Revenue This Year | $2.05 | N/A |
| Revenue Next Year | $4.48 | N/A |
| P/E Ratio | ★ N/A | $5.62 |
| Revenue Growth | ★ 1.59 | N/A |
| 52 Week Low | $1.43 | $1.20 |
| 52 Week High | $4.38 | $4.94 |
Technical Indicators
Market Signals| Indicator | DTI | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.67 | 43.81 |
| Support Level | $3.28 | $1.93 |
| Resistance Level | $3.92 | $2.30 |
| Average True Range (ATR) | 0.25 | 0.11 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 50.50 | 36.54 |
Price Performance
Historical ComparisonAbout DTI Drilling Tools International Corporation
Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.